(Q37995577)

26 August 2017

Tumor response assessments with diffusion and perfusion MRI. (English)

1 reference

magnetic resonance imaging

26 August 2017

0 references

2

Anwar R Padhani

1 reference

26 August 2017

Sonia P Li

1

1 reference

PubMed ID

22434697

26 August 2017

language of work or name

1 reference

1 April 2012

1 reference

Journal of Magnetic Resonance Imaging

26 August 2017

1 reference

26 August 2017

35

1 reference

26 August 2017

4

1 reference

26 August 2017

745-763

1 reference

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

26 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

We should desist using RECIST, at least in GIST.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Diffusion-weighted MRI in the body: applications and challenges in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Technology insight: water diffusion MRI--a potential new biomarker of response to cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Extracranial applications of diffusion-weighted magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Diffusion MR imaging for monitoring of treatment response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Tumors in Pediatric Patients at Diffusion-weighted MR Imaging: Apparent Diffusion Coefficient and Tumor Cellularity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Correlation of diffusion-weighted magnetic resonance data with cellularity in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Diffusion-weighted imaging for non-invasive and quantitative monitoring of bone marrow infiltration in patients with monoclonal plasma cell disease: a comparative study with histology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Diffusion Weighted Magnetic Resonance Imaging of metastatic bone disease: A biomarker for treatment response monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Diffusion-weighted imaging of prostate cancer: correlation between apparent diffusion coefficient values and tumor proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Monitoring of gliomas in vivo by diffusion MRI and (1)H MRS during gene therapy-induced apoptosis: interrelationships between water diffusion and mobile lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

FDG PET/CT and diffusion-weighted imaging for breast cancer: prognostic value of maximum standardized uptake values and apparent diffusion coefficient values of the primary lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Diffusion MRI for prediction of response of rectal cancer to chemoradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Apparent diffusion coefficient: potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Tumour necrosis is an independent prognostic marker in non-small cell lung cancer: correlation with biological variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

High-b-value diffusion-weighted MR imaging for pretreatment prediction and early monitoring of tumor response to therapy in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: preliminary analysis of diffusion-weighted MR imaging for early detection of tumor histopathologic downstaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Diffusion-weighted MR imaging: pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Effect of vascular targeting agent in rat tumor model: dynamic contrast-enhanced versus diffusion-weighted MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Reproducibility and changes in the apparent diffusion coefficients of solid tumours treated with combretastatin A4 phosphate and bevacizumab in a two-centre phase I clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Predicting and monitoring cancer treatment response with diffusion-weighted MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Unresectable hepatocellular carcinoma: serial early vascular and cellular changes after transarterial chemoembolization as detected with MR imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

The value of diffusion-weighted imaging for monitoring the chemotherapeutic response of osteosarcoma: a comparison between average apparent diffusion coefficient and minimum apparent diffusion coefficient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Diffusion-weighted magnetic resonance imaging allows monitoring of anticancer treatment effects in patients with soft-tissue sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Dynamic contrast-enhanced and diffusion MRI show rapid and dramatic changes in tumor microenvironment in response to inhibition of HIF-1alpha using PX-478.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Early detection of radiation therapy response in non-Hodgkin's lymphoma xenografts by in vivo 1H magnetic resonance spectroscopy and imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Diffusion magnetic resonance imaging: an imaging treatment response biomarker to chemoradiotherapy in a mouse model of squamous cell cancer of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Monitoring T2 and ADC at 9.4 T following fractionated external beam radiation therapy in a mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of therapeutic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Imaging response criteria for recurrent gliomas treated with bevacizumab: role of diffusion weighted imaging as an imaging biomarker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Diffusion-weighted MRI of advanced hepatocellular carcinoma during sorafenib treatment: initial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Diffusion-weighted magnetic resonance imaging allows noninvasive in vivo monitoring of the effects of combretastatin a-4 phosphate after repeated administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Informatics in Radiology (infoRAD): Magnetic Resonance Imaging Workbench: analysis and visualization of dynamic contrast-enhanced MR imaging data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Perfusion MRI in the early clinical development of antivascular drugs: decorations or decision making tools?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Reproducibility of reference tissue quantification of dynamic contrast-enhanced data: comparison with a fixed vascular input function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Evaluation of response to treatment using DCE-MRI: the relationship between initial area under the gadolinium curve (IAUGC) and quantitative pharmacokinetic analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Dynamic magnetic resonance imaging of tumor perfusion. Approaches and biomedical challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Imaging tumor vascular heterogeneity and angiogenesis using dynamic contrast-enhanced magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Phase I evaluation of a fully human anti-alphav integrin monoclonal antibody (CNTO 95) in patients with advanced solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Identification of early predictive imaging biomarkers and their relationship to serological angiogenic markers in patients with ovarian cancer with residual disease following cytotoxic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Perfusion MR imaging of extracranial tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Microvessel density in invasive breast cancer assessed by dynamic gd-dtpa enhanced MRI

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Correlation of dynamic contrast enhancement MRI parameters with microvessel density and VEGF for assessment of angiogenesis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Vascular differences detected by MRI for metastatic versus nonmetastatic breast and prostate cancer xenografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

MRI enhancement and microvascular density in gliomas. Correlation with tumor cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

An exploratory study into the role of dynamic contrast-enhanced magnetic resonance imaging or perfusion computed tomography for detection of intratumoral hypoxia in head-and-neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Validation of dynamic contrast-enhanced magnetic resonance imaging-derived vascular permeability measurements using quantitative autoradiography in the RG2 rat brain tumor model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Dynamic MRI for imaging tumor microvasculature: comparison of susceptibility and relaxivity techniques in pelvic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Metabolic and vascular features of dynamic contrast-enhanced breast magnetic resonance imaging and (15)O-water positron emission tomography blood flow in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Measuring tumor perfusion in control and treated murine tumors: correlation of microbubble contrast-enhanced sonography to dynamic contrast-enhanced magnetic resonance imaging and fluorodeoxyglucose positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Dexamethasone and enhancing solitary cerebral mass lesions: alterations in perfusion and blood-tumor barrier kinetics shown by magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Pilot study of DCE-MRI to predict progression-free survival with sorafenib therapy in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Predicting survival and early clinical response to primary chemotherapy for patients with locally advanced breast cancer using DCE-MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Dynamic MR imaging (DEMRI) of microcirculation in bone sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Use of dynamic contrast-enhanced MR imaging to predict survival in patients with primary breast cancer undergoing neoadjuvant chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer a

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Dynamic contrast-enhanced magnetic resonance imaging pharmacodynamic biomarker study of sorafenib in metastatic renal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Inflammatory breast cancer: dynamic contrast-enhanced MR in patients receiving bevacizumab--initial experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Modeling tracer kinetics in dynamic Gd-DTPA MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Uncertainty in the analysis of tracer kinetics using dynamic contrast-enhancedT1-weighted MRI

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: comparison of quantitative and semi-quantitative analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Combretastatin A4 phosphate has tumor antivascular activity in rat and man as demonstrated by dynamic magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Quantifying spatial heterogeneity in dynamic contrast-enhanced MRI parameter maps

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

A feasibility study evaluating the functional diffusion map as a predictive imaging biomarker for detection of treatment response in a patient with metastatic prostate cancer to the bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Diffusion-weighted MRI: a new functional clinical technique for tumour imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Predicting Response of Colorectal Hepatic Metastasis: Value of Pretreatment Apparent Diffusion Coefficients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Diffusion-Weighted MRI of Peripheral Zone Prostate Cancer: Comparison of Tumor Apparent Diffusion Coefficient With Gleason Score and Percentage of Tumor on Core Biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

Tumour oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22838

21 January 2018

Identifiers

DOI

10.1002/JMRI.22838

1 reference

release_nkbj4pbfijepvctmlaihj4ijde

26 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nkbj4pbfijepvctmlaihj4ijde

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

22434697

1 reference

PubMed ID

22434697